TherapeuticsMD, Inc. (TXMD)

$6.4001

+0.42 (+7.03%)
Rating:
Recommendation:
Buy
Symbol TXMD
Price $6.4001
Beta 1.487
Volume Avg. 0.13M
Market Cap 60.590M
Shares () -
52 Week Range 1.99-30.5
1y Target Est -
DCF Unlevered TXMD DCF ->
DCF Levered TXMD LDCF ->
ROE 11.23% Buy
ROA -6.47% Neutral
Operating Margin -
Debt / Equity -377.41% Strong Sell
P/E -0.29 Neutral
P/B -1.23 Sell
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest TXMD news


Mr. Robert Finizio
Healthcare
Drug Manufacturers—Specialty & Generic
NASDAQ Global Select

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.